1. Home
  2. REAX vs VALN Comparison

REAX vs VALN Comparison

Compare REAX & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Real Brokerage Inc.

REAX

The Real Brokerage Inc.

N/A

Current Price

$2.44

Market Cap

792.1M

Sector

N/A

ML Signal

N/A

Logo Valneva SE

VALN

Valneva SE

N/A

Current Price

$10.50

Market Cap

875.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
REAX
VALN
Founded
2018
2012
Country
United States
France
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
792.1M
875.7M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
REAX
VALN
Price
$2.44
$10.50
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
4
Target Price
$5.55
$15.75
AVG Volume (30 Days)
1.8M
17.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$21.82
$2.58
Revenue Next Year
$18.31
$4.43
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.45
$5.43
52 Week High
$5.41
$12.25

Technical Indicators

Market Signals
Indicator
REAX
VALN
Relative Strength Index (RSI) 31.76 50.40
Support Level N/A $8.37
Resistance Level $4.42 $12.22
Average True Range (ATR) 0.18 0.40
MACD 0.02 -0.09
Stochastic Oscillator 6.14 22.94

Price Performance

Historical Comparison
REAX
VALN

About REAX The Real Brokerage Inc.

The Real Brokerage Inc is a technology-powered real estate brokerage firm located in the United States and Canada. It has developed a proprietary transaction management and brokerage operations software called reZEN, which powers nearly all of its brokerage operations, enabling efficiency, automation, and flexibility by incorporating end-to-end transaction management, automated compliance and brokerage oversight, integrated payments and financial services, Leo CoPilot, and open API for customization. In addition, the company also offers mortgage brokering and title services. The company's operating segments are North American Brokerage, which derives key revenue, One Real Title, One Real Mortgage, and Real Wallet. Geographically, it derives key revenue from the United States.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: